Depemokimab, sold under the brand name Exdensur, is a humanized monoclonal antibody used for the treatment of asthma. Depemokimab is an interleukin-5 (IL-5) antagonist monoclonal antibody (humanized immunoglobulin G1 [IgG1] kappa).
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.